ischaemic heart disease, heart failure or cerebrovascular disease
GLP-1 is a multifaceted hormone, and the use of its analogs is associated with broad metabolic effects: they increase insulin secretion, decrease glucagon release, increase glucose uptake in muscles, decrease glucose production in the liver, improve lipid profile, slow gastric emptying, and increase satiety leading to weight loss ( GLP-1RA have been used to treat T2D for ~20 years, and they have transformed T2D management in pediatric and adult populations ( 4.1 HbA1c reduction 4.1.1 Uncontrolled studies In a small, uncontrolled study, weekly semaglutide in 10 patients with newly diagnosed T1D, mean HbA1c improved dramatically from 11.7 2.1% to 5.7 0.4% at 12 months ( 4.1.2 RCTs Several blinded, placebo-controlled RCTs have demonstrated a significant reduction in HbA1c when adding GLP-1RA to either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), ranging between 0.1-0.7% ( Table 1 )
Vellakoil, Merta City, Sivaganga, Mandideep, Sailu, Vyara, Kovvur, Vadalur, Nawabganj
Amino Acids 37 , 111122 (2009)
This helped me avoid nausea, eat the amount of calories I needed, and prevented my sugars getting too low
Review and/or revision of the manuscript: A.K., A.O
